AstraZeneca Gross Profit 1992-2025 | AZN
AstraZeneca annual/quarterly gross profit history and growth rate from 1992 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- AstraZeneca gross profit for the quarter ending June 30, 2025 was $11.984B, a 11.43% increase year-over-year.
- AstraZeneca gross profit for the twelve months ending June 30, 2025 was $45.981B, a 14.01% increase year-over-year.
- AstraZeneca annual gross profit for 2024 was $43.866B, a 16.84% increase from 2023.
- AstraZeneca annual gross profit for 2023 was $37.543B, a 17.47% increase from 2022.
- AstraZeneca annual gross profit for 2022 was $31.96B, a 27.94% increase from 2021.
| AstraZeneca Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $43,866 |
| 2023 | $37,543 |
| 2022 | $31,960 |
| 2021 | $24,980 |
| 2020 | $21,318 |
| 2019 | $19,463 |
| 2018 | $17,154 |
| 2017 | $18,147 |
| 2016 | $18,876 |
| 2015 | $20,062 |
| 2014 | $20,705 |
| 2013 | $20,545 |
| 2012 | $22,580 |
| 2011 | $27,565 |
| 2010 | $26,880 |
| 2009 | $27,029 |
| 2008 | |